Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hagay Sobol

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Genetic Testing and Molecular Biomarkers|March 14, 2014
About sequence quality: impact on clinical applicationsTetsuro Noguchi, Violaine Bourdon, Hagay Sobol
BMC Neurology|January 25, 2011
SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosisGuillaume Rousseau, Tetsuro Noguchi, Violaine Bourdon, et al.
Journal of Community Genetics|August 18, 2015
Genetic professionals' views on genetic counsellors: a French surveyChristophe Cordier, Nicolas Taris, Ramona Moldovan, et al.
Medecine Sciences : M/S|September 14, 2004
[The supply of breast/ovarian cancer genetic susceptibility tests in France]Christine Sevilla, Pascale Bourret, Catherine Noguès, et al.
International Journal of Medical Sciences|September 5, 2008
Acceptability of cancer chemoprevention trials: impact of the designAnne-Sophie Maisonneuve, Laetitia Huiart, Laetitia Rabayrol, et al.
Familial Cancer|December 13, 2005
Behavioral and economic impact of a familial history of cancersFrancois Eisinger, Carole Tarpin, Laetitia Huiart, et al.
Oncology Reports|June 21, 2006
Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumourFrançois Bertucci, Anthony Goncalves, Geneviève Monges, et al.
Genes, Chromosomes & Cancer|September 16, 2010
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancerRenaud Sabatier, José Adélaïde, Pascal Finetti, et al.
Journal of Clinical Epidemiology|August 6, 2002
Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultationLaetitia Huiart, François Eisinger, Dominique Stoppa-Lyonnet, et al.
International Journal of Technology Assessment in Health Care|July 17, 2003
Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testingChristine Sevilla, Claire Julian-Reynier, François Eisinger, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Genetic Testing and Molecular Biomarkers|March 14, 2014
About sequence quality: impact on clinical applicationsTetsuro Noguchi, Violaine Bourdon, Hagay Sobol
BMC Neurology|January 25, 2011
SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosisGuillaume Rousseau, Tetsuro Noguchi, Violaine Bourdon, et al.
Journal of Community Genetics|August 18, 2015
Genetic professionals' views on genetic counsellors: a French surveyChristophe Cordier, Nicolas Taris, Ramona Moldovan, et al.
Medecine Sciences : M/S|September 14, 2004
[The supply of breast/ovarian cancer genetic susceptibility tests in France]Christine Sevilla, Pascale Bourret, Catherine Noguès, et al.
International Journal of Medical Sciences|September 5, 2008
Acceptability of cancer chemoprevention trials: impact of the designAnne-Sophie Maisonneuve, Laetitia Huiart, Laetitia Rabayrol, et al.
Familial Cancer|December 13, 2005
Behavioral and economic impact of a familial history of cancersFrancois Eisinger, Carole Tarpin, Laetitia Huiart, et al.
Oncology Reports|June 21, 2006
Acquired resistance to imatinib and secondary KIT exon 13 mutation in gastrointestinal stromal tumourFrançois Bertucci, Anthony Goncalves, Geneviève Monges, et al.
Genes, Chromosomes & Cancer|September 16, 2010
BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancerRenaud Sabatier, José Adélaïde, Pascal Finetti, et al.
Journal of Clinical Epidemiology|August 6, 2002
Effects of genetic consultation on perception of a family risk of breast/ovarian cancer and determinants of inaccurate perception after the consultationLaetitia Huiart, François Eisinger, Dominique Stoppa-Lyonnet, et al.
International Journal of Technology Assessment in Health Care|July 17, 2003
Impact of gene patents on the cost-effective delivery of care: the case of BRCA1 genetic testingChristine Sevilla, Claire Julian-Reynier, François Eisinger, et al.
Pageof 7